Mani Foroohar
Stock Analyst at Leerink Partners
(1.48)
# 3,192
Out of 4,712 analysts
180
Total ratings
40.59%
Success rate
-13.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mani Foroohar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals | Maintains: Outperform | $46 → $44 | $11.68 | +276.71% | 10 | Nov 19, 2024 | |
| LXEO Lexeo Therapeutics | Maintains: Outperform | $20 → $19 | $6.35 | +199.21% | 2 | Nov 13, 2024 | |
| NGNE Neurogene | Maintains: Outperform | $45 → $72 | $22.62 | +218.30% | 2 | Nov 12, 2024 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | $17 | $6.90 | +146.38% | 1 | Nov 5, 2024 | |
| MIRM Mirum Pharmaceuticals | Maintains: Outperform | $47 → $49 | $42.17 | +16.20% | 11 | Oct 17, 2024 | |
| BBIO BridgeBio Pharma | Maintains: Outperform | $47 → $46 | $28.53 | +61.23% | 15 | Oct 17, 2024 | |
| WVE Wave Life Sciences | Maintains: Outperform | $20 → $22 | $13.41 | +64.06% | 6 | Oct 16, 2024 | |
| FDMT 4D Molecular Therapeutics | Reiterates: Outperform | $40 → $36 | $5.81 | +519.62% | 8 | Sep 19, 2024 | |
| RXRX Recursion Pharmaceuticals | Maintains: Market Perform | $9 → $8 | $7.24 | +10.50% | 7 | Sep 3, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Outperform | $53 → $62 | $36.53 | +69.72% | 15 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $11.58 | +12.26% | 1 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $29 | $19.73 | +46.98% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $230 | $121.90 | +88.68% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $4 | $2.99 | +33.78% | 2 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $7.40 | - | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $6.32 | +390.51% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $1 | $0.47 | +110.88% | 10 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.66 | +321.69% | 1 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $40 | $19.63 | +103.77% | 12 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $111 → $93 | $40.27 | +130.94% | 17 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $86 → $84 | $12.05 | +597.10% | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $6 → $7 | $1.21 | +478.51% | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $180 → $160 | $7.79 | +1,953.92% | 10 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $77 | $28.81 | +167.27% | 2 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $144 → $143 | $243.25 | -41.21% | 11 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $5 → $6 | $5.68 | +5.63% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $76 | $40.94 | +85.64% | 1 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $34 | $1.69 | +1,911.83% | 4 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $50 → $20 | $4.74 | +321.94% | 6 | Jul 23, 2021 |
Rocket Pharmaceuticals
Nov 19, 2024
Maintains: Outperform
Price Target: $46 → $44
Current: $11.68
Upside: +276.71%
Lexeo Therapeutics
Nov 13, 2024
Maintains: Outperform
Price Target: $20 → $19
Current: $6.35
Upside: +199.21%
Neurogene
Nov 12, 2024
Maintains: Outperform
Price Target: $45 → $72
Current: $22.62
Upside: +218.30%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: $17
Current: $6.90
Upside: +146.38%
Mirum Pharmaceuticals
Oct 17, 2024
Maintains: Outperform
Price Target: $47 → $49
Current: $42.17
Upside: +16.20%
BridgeBio Pharma
Oct 17, 2024
Maintains: Outperform
Price Target: $47 → $46
Current: $28.53
Upside: +61.23%
Wave Life Sciences
Oct 16, 2024
Maintains: Outperform
Price Target: $20 → $22
Current: $13.41
Upside: +64.06%
4D Molecular Therapeutics
Sep 19, 2024
Reiterates: Outperform
Price Target: $40 → $36
Current: $5.81
Upside: +519.62%
Recursion Pharmaceuticals
Sep 3, 2024
Maintains: Market Perform
Price Target: $9 → $8
Current: $7.24
Upside: +10.50%
Ionis Pharmaceuticals
Jul 24, 2024
Upgrades: Outperform
Price Target: $53 → $62
Current: $36.53
Upside: +69.72%
Jul 22, 2024
Initiates: Outperform
Price Target: $13
Current: $11.58
Upside: +12.26%
Jul 2, 2024
Initiates: Outperform
Price Target: $29
Current: $19.73
Upside: +46.98%
Jun 24, 2024
Maintains: Outperform
Price Target: $165 → $230
Current: $121.90
Upside: +88.68%
Apr 25, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $2.99
Upside: +33.78%
Mar 6, 2024
Upgrades: Outperform
Price Target: n/a
Current: $7.40
Upside: -
Feb 20, 2024
Initiates: Outperform
Price Target: $31
Current: $6.32
Upside: +390.51%
Dec 22, 2023
Downgrades: Market Perform
Price Target: $1
Current: $0.47
Upside: +110.88%
Nov 30, 2023
Initiates: Outperform
Price Target: $7
Current: $1.66
Upside: +321.69%
May 12, 2023
Downgrades: Market Perform
Price Target: $40
Current: $19.63
Upside: +103.77%
Feb 24, 2023
Downgrades: Underperform
Price Target: $111 → $93
Current: $40.27
Upside: +130.94%
Jan 23, 2023
Maintains: Outperform
Price Target: $86 → $84
Current: $12.05
Upside: +597.10%
Jan 23, 2023
Maintains: Market Perform
Price Target: $6 → $7
Current: $1.21
Upside: +478.51%
Jan 23, 2023
Maintains: Market Perform
Price Target: $180 → $160
Current: $7.79
Upside: +1,953.92%
Jan 23, 2023
Maintains: Outperform
Price Target: $81 → $77
Current: $28.81
Upside: +167.27%
Jan 23, 2023
Maintains: Market Perform
Price Target: $144 → $143
Current: $243.25
Upside: -41.21%
Nov 14, 2022
Maintains: Market Perform
Price Target: $5 → $6
Current: $5.68
Upside: +5.63%
Nov 7, 2022
Maintains: Outperform
Price Target: $75 → $76
Current: $40.94
Upside: +85.64%
May 12, 2022
Maintains: Outperform
Price Target: $30 → $34
Current: $1.69
Upside: +1,911.83%
Jul 23, 2021
Maintains: Market Perform
Price Target: $50 → $20
Current: $4.74
Upside: +321.94%